Fortis Capital Management LLC Makes New Investment in Abbott Laboratories (NYSE:ABT)
Fortis Capital Management LLC bought a new position in Abbott Laboratories (NYSE:ABT – Free Report) during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm bought 14,209 shares of the healthcare product maker’s stock, valued at approximately $1,376,000. A number of […]